The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: sandostatin     Quarter: 2016Q3

Total Records: 2,045     Number of Pages: 103

DRUGNAME PT EventCount
SANDOSTATIN Wound infection 3
SANDOSTATIN LAR DEPOT Abnormal behaviour 3
SANDOSTATIN LAR DEPOT Abscess oral 3
SANDOSTATIN LAR DEPOT Activities of daily living impaired 3
SANDOSTATIN LAR DEPOT Anal abscess 3
SANDOSTATIN LAR DEPOT Aortic aneurysm 3
SANDOSTATIN LAR DEPOT Apathy 3
SANDOSTATIN LAR DEPOT Benign neoplasm of adrenal gland 3
SANDOSTATIN LAR DEPOT Bladder neoplasm 3
SANDOSTATIN LAR DEPOT Blood gastrin increased 3
SANDOSTATIN LAR DEPOT Body height increased 3
SANDOSTATIN LAR DEPOT Body mass index increased 3
SANDOSTATIN LAR DEPOT Bone cancer 3
SANDOSTATIN LAR DEPOT Bone erosion 3
SANDOSTATIN LAR DEPOT Bone fissure 3
SANDOSTATIN LAR DEPOT Bradycardia 3
SANDOSTATIN LAR DEPOT Bronchial disorder 3
SANDOSTATIN LAR DEPOT Cachexia 3
SANDOSTATIN LAR DEPOT Central obesity 3
SANDOSTATIN LAR DEPOT Chondroma 3

Total Records: 2,045     Number of Pages: 103